Palogic Value Management’s Brunswick BC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.05M Buy
24,316
+106
+0.4% +$8.5K 0.67% 33
2026
Q1
$1.76M Sell
24,210
-3,886
-14% -$313K 0.74% 30
2025
Q4
$2.09M Buy
28,096
+514
+2% +$34.8K 0.87% 32
2025
Q3
$1.74M Buy
27,582
+5
+0% +$310 0.7% 38
2025
Q2
$1.52M Buy
27,577
+2,300
+9% +$116K 0.62% 47
2025
Q1
$1.36M Buy
25,277
+1,134
+5% +$71.1K 0.59% 58
2024
Q4
$1.56M Buy
24,143
+56
+0.2% +$4.39K 0.59% 53
2024
Q3
$2.02M Buy
24,087
+234
+1% +$18.2K 0.69% 43
2024
Q2
$1.74M Sell
23,853
-1,903
-7% -$155K 0.74% 46
2024
Q1
$2.49M Buy
25,756
+28
+0.1% +$2.46K 1.08% 29
2023
Q4
$2.49M Buy
25,728
+373
+1% +$29.6K 1.1% 32
2023
Q3
$2M Sell
25,355
-39
-0.2% -$3.21K 0.95% 32
2023
Q2
$2.2M Sell
25,394
-79
-0.3% -$6.45K 1.03% 32
2023
Q1
$2.09M Buy
25,473
+676
+3% +$55.9K 1.02% 27
2022
Q4
$1.79M Buy
+24,797
New +$1.76M 0.93% 36

Other funds holding BC

Palogic Value Management's BC Position: Q2 2026 in Review

Palogic Value Management increased its Brunswick (BC) stake by 0.44% in Q2 2026, buying an estimated $8.5K and bringing the position to 24,316 shares worth $2.05M. The position accounts for 0.67% of the portfolio, ranked #33.

Palogic Value Management first reported a position in BC in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.49M in Q4 2023. 471 funds tracked by Wall St. Rank hold BC as of Q2 2026.

  • Palogic Value Management held 24,316 shares of Brunswick worth $2.05M as of Q2 2026.
  • Palogic Value Management bought 106 Brunswick shares in Q2 2026, an estimated $8.5K.
  • Brunswick made up 0.67% of Palogic Value Management's portfolio in Q2 2026, its #33 holding.
  • Palogic Value Management first reported a position in Brunswick in Q4 2022 and has held it in 15 quarters since.
  • Palogic Value Management's Brunswick position peaked at $2.49M in Q4 2023.
  • 471 funds tracked by Wall St. Rank held Brunswick as of Q2 2026.

Based on Palogic Value Management's 13F filing for Q2 2026, filed 14 Aug 2026.